APP and breast carcinoma: AR12 and the breast cancer drug neratinib (NER) rapidly reduced expression of Tau, amyloid precursor protein (APP), superoxide dismutase 1 (SOD1) and TAR DNA-binding protein 43 (TDP-43) [10, 12–14].